US Pharmaceutical Industry Faces Monkey Shortage Due to China Export Ban

• The US pharmaceutical industry faces a significant shortage of laboratory monkeys for research.
• China's 2020 export ban on laboratory monkeys has cut off a major supply source for the US.
• Rising costs and import restrictions have exacerbated the shortage.
• Laboratories have sought alternatives from Cambodia, raising ethical concerns.
• A US startup, backed by Joe Lonsdale, plans to breed 30,000 monkeys over two decades.